TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo

Jia Cao; Jiachun Yang; Vijaya Ramachandran; Thiruvengadam Arumugam; Defeng Deng; Zhaoshen Li; Leiming Xu; Craig D. Logsdon

doi:10.1371/journal.pone.0144969

Loading metrics

Open Access

Peer-reviewed

Research Article

TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo

Jia Cao ,

Contributed equally to this work with: Jia Cao, Jiachun Yang

¶‡ JC and JCY are co-first authors on this work. LMX and CDL also contributed equally to this work.

Affiliation Department of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China
⨯
Jiachun Yang ,

Contributed equally to this work with: Jia Cao, Jiachun Yang

¶‡ JC and JCY are co-first authors on this work. LMX and CDL also contributed equally to this work.

Affiliation Department of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China
⨯
Vijaya Ramachandran,

Affiliation Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States of America
⨯
Thiruvengadam Arumugam,

Affiliation Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States of America
⨯
Defeng Deng,

Affiliation Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States of America
⨯
Zhaoshen Li,

Affiliation Department of Gastroenterology, Changhai Hospital, the Second Military Medical University, Shanghai, 200433, China
⨯
Leiming Xu ,

* E-mail: leiming.xu@aliyun.com (LMX); clogsdon@mdanderson.org (CDL)

¶‡ JC and JCY are co-first authors on this work. LMX and CDL also contributed equally to this work.

Affiliation Department of Gastroenterology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200092, China
⨯
Craig D. Logsdon

* E-mail: leiming.xu@aliyun.com (LMX); clogsdon@mdanderson.org (CDL)

¶‡ JC and JCY are co-first authors on this work. LMX and CDL also contributed equally to this work.

Affiliation Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, United States of America
⨯

TM4SF1 Promotes Gemcitabine Resistance of Pancreatic Cancer In Vitro and In Vivo

Jia Cao,
Jiachun Yang,
Vijaya Ramachandran,
Thiruvengadam Arumugam,
Defeng Deng,
Zhaoshen Li,
Leiming Xu,
Craig D. Logsdon

Published: December 28, 2015
https://doi.org/10.1371/journal.pone.0144969

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Pancreatic cancer
Is the Subject Area "Pancreatic cancer" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Transfection
Is the Subject Area "Transfection" applicable to this article?

Thanks for your feedback.
Small interfering RNA
Is the Subject Area "Small interfering RNA" applicable to this article?

Thanks for your feedback.
Breast cancer
Is the Subject Area "Breast cancer" applicable to this article?

Thanks for your feedback.
Apoptosis
Is the Subject Area "Apoptosis" applicable to this article?

Thanks for your feedback.
Cell proliferation
Is the Subject Area "Cell proliferation" applicable to this article?

Thanks for your feedback.